Phase II trial of gemcitabine plus carboplatin for urothelial transitional cell carcinoma (UTCC) in advanced or metastatic stage

被引：0
|
作者：
Santoro, A
Santoro, M
Maiorino, L
Forestieri, V
Forestieri, P
机构：
[1] San Gennaro Hosp, OU Med Oncol, Naples, Italy
[2] Univ Naples Federico II, Chair Oncol Surg, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
647
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [1] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
    Nong Xu
    Xiao Chen Zhang
    Jian Ping Xiong
    Wei Jia Fang
    Lan Fang Yu
    Jiong Qian
    Ling Zhang
    [J]. BMC Cancer, 7
  • [2] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
    Xu, Nong
    Zhang, Xiao Chen
    Xiong, Jian Ping
    Fang, Wei Jia
    Yu, Lan Fang
    Qian, Jiong
    Zhang, Ling
    [J]. BMC CANCER, 2007, 7 (1)
  • [3] A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium
    von der Maase, H.
    Lehmann, J.
    Gravis, G.
    Joensuu, H.
    Geertsen, P. F.
    Gough, J.
    Chen, G.
    Kania, M.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (10) : 1533 - 1538
  • [4] Phase II trial of gemcitabine, carboplatin, and bevacizumab (Bev) in patients (pts) with advanced/metastatic urothelial carcinoma (UC).
    Balar, A. V.
    Milowsky, M. I.
    Apolo, A. B.
    Ostrovnaya, I.
    Iasonos, A.
    Trout, A.
    Regazzi, A. M.
    Garcia-Grossman, I. R.
    Gallagher, D. J.
    Bajorin, D. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Phase II trial of paclitaxel and carboplatin in advanced/metastatic transitional cell cancer
    Wille, AH
    Johannsen, M
    Roigas, J
    Schnorr, DR
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 380 - 381
  • [6] Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: A phase II multicenter trial
    Lorusso, V
    Manzione, L
    De Vita, F
    Antimi, M
    Selvaggi, FP
    De Lena, M
    [J]. JOURNAL OF UROLOGY, 2000, 164 (01): : 53 - 56
  • [7] Carboplatin and gemcitabine in patients with advanced and/or metastatic urothelial cancers: A phase II study
    Baitar, Abdelbari
    De Vos, Machteld
    Vandebroek, An
    Schrijvers, Dirk
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2011, 2 (01) : 31 - 35
  • [8] A phase II trial of pemetrexed plus gemcitabine as first-line treatment for locally advanced or metastatic transitional cell carcinoma of the urothelium
    von der Maase, H
    Lehmann, J
    Gravis, G
    Joensuu, H
    Bihn, B
    Geertsen, P
    Gough, J
    Chen, ZJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 400S - 400S
  • [9] Phase II trial of gemcitabine, carboplatin, and bevacizumab in chemotherapy-naive patients (Pts) with advanced/metastatic urothelial carcinoma (UC)
    Balar, A. V.
    Milowsky, M. I.
    Apolo, A. B.
    Ostrovnaya, I.
    Iasonos, A.
    Trout, A.
    Regazzi, A. M.
    Garcia-Grossman, I. R.
    Gallagher, D. J.
    Bajorin, D. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [10] Tislelizumab plus cisplatin/carboplatin and gemcitabine versus placebo plus cisplatin/carboplatin and gemcitabine in Chinese patients with advanced urothelial carcinoma: A phase III trial in progress
    Bi, Feng
    Li, Han-Zhong
    Zhu, Shaoxing
    Zou, Qing
    Tang, Jia
    Zhang, Wei
    Ye, Dingwei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345